Home › Research › Topics › mini-mental
mini-mental
847 studies tagged mini-mental, dated 1982-05-01 to 2026-09-16. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Feasibility of remote self-administered cognitive assessment in an Alzheimer's disease treatment clinic 2026-09-16
- Structural brain imaging for newly diagnosed cognitive impairment by Medicare coverage type 2026-09-15
- Detection and Continuous Monitoring of Memory Dysfunction in Mild Cognitive Impairment and Healthy Aging Through Adaptive Computational Phenotyping 2026-09-12
Studies
847 studies carry this tag.
Date range
1982 to 2026
Top journals
- Neurology 63
- Journal of Alzheimer's disease : JAD 31
- Archives of neurology 30
- Alzheimer s & Dementia 25
- Alzheimer's & dementia : the journal of the Alzheimer's Association 21
315 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Oxidative damage occurs in the brain of subjects with mild cognitive impairment, suggesting that oxidative damage may be one of the earliest events in the onset and progression of Alzheimer disease.
-
60/100
MCI as an entity is evolving and somewhat controversial.
-
Identifying pre-clinical Alzheimer's disease (AD) in subjects with mild cognitive impairment (MCI) is a major issue in clinical diagnosis.
-
To compare the diagnostic accuracies of the Revised Hasegawa Dementia Scale (HDS-R) and Mini-Mental Status Examination (MMSE) for Alzheimer's diseases (AD), we administered them simultaneously to 82 AD patients and 82 age- and sex-matched nondemented control subjects.
-
From a prospective Memory Clinic cohort including consecutively referred patients, age 60 years or above, and with MMSE score 20 or above, 36 patients with AD and 30 with MCI were included in this study.
-
The authors assessed whether measures of hippocampal water diffusivity at baseline can predict future progression to Alzheimer disease (AD) in amnestic mild cognitive impairment (aMCI).
-
Nearly all persons had at least some AD pathology.
-
65/100
Mild cognitive impairment (MCI) often represents an early form of Alzheimer disease (AD).
-
The objective of this study was to assess the prevalence and pattern of neuropsychological impairment in cohorts of human immunodeficiency virus (HIV)-infected individuals across pre- and post-HAART (highly active antiretroviral therapy) eras.
-
Approximately 40% of the subjects were APOE epsilon4 carriers.
-
58/100
Physicians noted impairment in a minority of impaired patients.
-
The concept of cognitive impairment intervening between normal ageing and very early dementia has been in the literature for many years.
-
The First Key Symposium was held in Stockholm, Sweden, 2-5 September 2003.
-
55/100
The mean follow-up period for the cohort was 34 months.
-
Within a heterogenous group of MCI patients, including many with clinically significant CVD, baseline memory and executive performance significantly predicted likelihood to develop dementia.
-
In this community-based sample, 3 to 4% of nondemented persons met MCI operational criteria; despite increased risk of progressing to dementia, a substantial proportion also remained stable or reverted to normal during follow-up.
-
Medical record documentation reflects physician recognition of dementia, yet physicians are aware of, but have not documented, many patients with milder cognitive impairment.
-
There is a well-documented tendency for cognitive tests to underestimate the abilities of older people in black and minority ethnic groups.
-
Cholinesterase inhibitors positively affect cognition in Alzheimer's disease (AD) and other conditions, but no controlled functional MRI studies have examined where their effects occur in the brain.
-
Mild cognitive impairment (MCI) is considered to be a transitional stage between normal aging and dementia.
-
The real prevalence of dementia in a given population must be determined through prevalence studies, using validated screening tests.
-
The DemTect is short (8-10 minutes), easy to administer, and its transformed total score (maximum 18) is independent of age and education.
-
In this study we investigated impaired awareness of cognitive deficits in patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD).
-
Patients with MCI had a predominant memory impairment with relative sparing of other cognitive domains and were intermediate between clinically normal individuals and patients with AD on cognitive and functional ratings.
-
The Mini-Mental State Examination (MMSE) is the most widely used brief screening measure of cognition, but it is not sensitive in detecting mild memory or other cognitive impairments.
-
Twenty-two percent of the participants aged 75 years or older had MCI.
-
The development of MCI is associated with measurements of cognition and depression, racial and constitutional factors, and cerebrovascular disease.
-
When applied post hoc to an existing population, the Mini-Cog was as effective in detecting dementia as longer screening and assessment instruments.
-
Mild cognitive impairment (MCI), an intermediate state between normal aging and dementia, is characterized by acquired cognitive deficits, without significant decline in functional activities of daily living.
-
This study investigated cross-sectional and longitudinal neuropsychological data from 55 patients: 38 with Alzheimer's disease and 18 with mild cognitive impairment (MCI).
-
Mild cognitive impairment (MCI) is a recently described syndrome that is currently thought of as a transition phase between healthy cognitive ageing and dementia.
-
As public awareness of Alzheimer's disease increases, more people are asking for help and advice about memory problems.
-
Conventionally defined MCI has reasonable predictive value and specificity for AD.
-
42/100
Patients were enrolled in a prospective study on early cognitive impairment carried out in a Memory Clinic.
-
The lack of effective predictors of the rate of dementia progression extends to the very earliest stages of the disease, including what is often called MCI.
-
Dementia and MCI are associated with neuropsychiatric symptoms in clinical samples.
-
56/100
The six-item screener is a brief and reliable instrument for identifying subjects with cognitive impairment and its diagnostic properties are comparable to the full MMSE.
-
On average, persons with mild cognitive impairment had significantly lower scores at baseline in all cognitive domains.
-
The objective of this study was to describe the occurrence of HIV dementia and neuropsychological testing abnormalities in a new cohort of HIV-seropositive individuals at high risk for HIV dementia and to compare these results to a cohort before the advent of highly active antiretroviral therapy (HAART).
-
These findings indicate that in patients with MCI, the patient's lack of awareness of functional deficits identified by informants strongly predicts a future diagnosis of AD.
-
The results of this study showed that the Turkish version of the SMMSE has high reliability and validity for the diagnosis of mild dementia in Turkish population.
-
The field of aging and dementia is focusing on the characterization of the earliest stages of cognitive impairment.
-
39/100
This article discusses the potential of three assessments of language function in the diagnosis of Alzheimer-type dementia (DAT).
-
48/100
Data point to a role for midlife vascular risk factors in the development of MCI in late life.
-
Mean age was 74.5 years and 65.5% of them were illiterate.
-
There were insufficient data to make any recommendations regarding cognitive screening of asymptomatic individuals.
-
Hippocampal ADC was significantly different between control subjects and MCI patients, many of whom likely have preclinical Alzheimer disease.
-
Individuals currently characterized as having MCI progress steadily to greater stages of dementia severity at rates dependent on the level of cognitive impairment at entry and they almost always have the neuropathologic features of AD.
-
MCI criteria perform poorly when applied to a representative population sample.
-
The Mini-Mental State (MMS) is a brief structured test of cognitive function.
From across this tag
9 of the 846 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 9. The same 9 appear here every time.
- Physical Activity and Exercise in Mild Cognitive Impairment and Dementia: An Umbrella Review of Intervention and Observational Studies
- Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis
- Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition
- Comparative Evaluation of the Montreal Cognitive Assessment Basic Scale Against the Mini-Mental State Examination for Post-Stroke Cognitive Impairment
- Normative data of the Spanish version of the Montreal Cognitive Assessment (MoCA) in older individuals from Peru
- Feasibility of remote self-administered cognitive assessment in an Alzheimer's disease treatment clinic
- Dynamic cerebral autoregulation in people with mild cognitive impairment
- Conventional and neuropsychological criteria for mild cognitive impairment show similar prognostic value for dementia across 12 years in a non-clinical setting
- Risk of Conversion to Dementia in a Mild Behavioral Impairment Group Compared to a Psychiatric Group and to a Mild Cognitive Impairment Group